A new oral antibiotic for treating complicated urinary tract infections will be available following approval by the FDA.
“UTIs are common infections that are usually contained inside the bladder and do not cause back pain,” notes Barbara Hanna, DO, ob/gyn and co-founder of MyMenopauseRx.com. They happen when bacteria ...
Exblifep is a combination product that consists of cefepime, a cephalosporin antibacterial, and enmetazobactam, a beta-lactamase inhibitor. The Food and Drug Administration (FDA) has approved Exblifep ...
Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...
First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...
The FDA has approved GSK’s antibiotic for adults with complicated UTIs, providing an alternative to standard intravenous care ...
Infections in the lower urinary tract rarely migrate to the kidneys, but the precise mechanism that the human body employs to keep the twin organs disease-free has remained a medical mystery—until now ...
Untreated UTIs in pregnancy can progress to kidney infection (pyelonephritis), trigger preterm labour, or contribute to low ...
Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results